175 related articles for article (PubMed ID: 22434789)
1. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.
VanderLaan PA; Marqusee E; Krane JF
Cancer Cytopathol; 2012 Aug; 120(4):245-53. PubMed ID: 22434789
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
[TBL] [Abstract][Full Text] [Related]
3. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.
Liu X; Medici M; Kwong N; Angell TE; Marqusee E; Kim MI; Larsen PR; Cho NL; Nehs MA; Ruan DT; Gawande A; Moore F; Barletta J; Krane JF; Cibas ES; Yang T; Alexander EK
Thyroid; 2016 Feb; 26(2):256-61. PubMed ID: 26563459
[TBL] [Abstract][Full Text] [Related]
4. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
5. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
6. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
7. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.
Kiernan CM; Broome JT; Solórzano CC
Ann Surg Oncol; 2014 Oct; 21(11):3522-7. PubMed ID: 24796967
[TBL] [Abstract][Full Text] [Related]
8. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
9. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
Li W; Sciallis A; Lew M; Pang J; Jing X
Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
[TBL] [Abstract][Full Text] [Related]
10. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
[TBL] [Abstract][Full Text] [Related]
11. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category.
Mahajan A; Lin X; Nayar R
Cytopathology; 2013 Apr; 24(2):85-91. PubMed ID: 22356185
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
14. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines.
Kurian EM; Dawlett M; Wang J; Gong Y; Guo M
Diagn Cytopathol; 2012 May; 40 Suppl 1():E69-73. PubMed ID: 21538966
[TBL] [Abstract][Full Text] [Related]
15. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration.
Monaco SE; Pantanowitz L; Khalbuss WE; Benkovich VA; Ozolek J; Nikiforova MN; Simons JP; Nikiforov YE
Cancer Cytopathol; 2012 Oct; 120(5):342-50. PubMed ID: 22605559
[TBL] [Abstract][Full Text] [Related]
17. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
Lee YB; Cho YY; Jang JY; Kim TH; Jang HW; Chung JH; Oh YL; Kim SW
Head Neck; 2017 Feb; 39(2):269-274. PubMed ID: 27617626
[TBL] [Abstract][Full Text] [Related]
18. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
Wu HH; Rose C; Elsheikh TM
Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
[TBL] [Abstract][Full Text] [Related]
19. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
Hang JF; Lilo MT; Bishop JA; Ali SZ
Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
